Logo Image
News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademyShortsSponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Events
Webcasts
Event Calendar

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Events
  • Subscribe
  • Event Calendar
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
Clinical Operations & Strategy|
Patient Participation
Advertisement

Natasha Blakeney, MPH

Advertisement

Articles by Natasha Blakeney, MPH

i4-840068-1408526815305.jpg

Making a Difference in Cancer Trials Accrual

ByDebra Wujcik, PhD, RN, FAAN,Natasha Blakeney, MPH,Margo Michaels, MPH, ENACCT
April 1st 2014

Applied Clinical Trials

The integration of pre-screening all patients for eligibility in oncology studies.

table4-828006-1408529573898.png

Making a Difference in Clinical Trials Accrual: The Integration of Prescreening All Patients for Eligibility

ByDebra Wujcik, PhD, RN, FAAN,Natasha Blakeney, MPH,Margo Michaels, MPH, ENACCT
November 8th 2013

Applied Clinical Trials

Physician participation in and patient access to cancer treatment clinical trials (CCTs) are key measures for delivery of quality cancer care.

Advertisement

Latest Updated Articles

  • i4-840068-1408526815305.jpg
    Making a Difference in Cancer Trials Accrual

    April 1st 2014

  • table4-828006-1408529573898.png
    Making a Difference in Clinical Trials Accrual: The Integration of Prescreening All Patients for Eligibility

    November 8th 2013



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion

2

ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation

3

Bringing the Voice of Clinical Practice and Patients into Drug Development

4

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

5

Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us